Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Oberley, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Oberley, L. W.
[Cancer Research 62, 1205-1212, February 15, 2002]
© 2002 American Association for Cancer Research


Tumor Biology

Overexpression of Copper Zinc Superoxide Dismutase Suppresses Human Glioma Cell Growth1

Ying Zhang, Weiling Zhao, Hannah J. Zhang, Frederick E. Domann and Larry W. Oberley2

Free Radical and Radiation Biology Program, Department of Radiation Oncology, B180 Medical Laboratories, College of Medicine, The University of Iowa, Iowa City, Iowa 52242

Copper zinc superoxide dismutase (CuZnSOD) is an essential primary antioxidant enzyme that converts superoxide radical to hydrogen peroxide and molecular oxygen in the cytoplasm. Cytosolic glutathione peroxidase (GPx) converts hydrogen peroxide into water. The overall goal of the present study was to explore the possible role of the antioxidant enzyme CuZnSOD in expression of the malignant phenotype. We hypothesized that overexpression of CuZnSOD would lead to the suppression of at least part of the human malignant phenotype. To test this hypothesis, human CuZnSOD cDNA was transfected into U118-9 human malignant glioma cells. CuZnSOD activity levels increased 1.5-, 2.0-, 2.6-, and 3.5-fold, respectively, in four table transfected cell lines compared with wild type and vector controls. Overexpression of CuZnSOD altered cellular antioxidant enzyme profiles, including those of manganese superoxide dismutase, catalase, and GPx. The transfected clone with the highest CuZnSOD:GPx ratio (3.5) showed a 42% inhibition of tumor cell growth in vitro. The decreased rate of tumor cell growth in vitro was strongly correlated with the enzyme activity ratio of CuZnSOD:GPx. Glioma cells that stably overexpressed CuZnSOD demonstrated additional suppressive effects on the malignant phenotype when compared with the parental cells and vector controls. These cells showed decreased plating efficiency, elongated cell population doubling time, lower clonogenic fraction in soft agar, and, more significantly, inhibition of tumor formation in nude mice. This work suggested that CuZnSOD is a new tumor suppressor gene. Increased intracellular ROS levels were found in cells with high activity ratios of CuZnSOD:GPx. Change in the cellular redox status, especially change attributable to the accumulation of hydrogen peroxide or other hydroperoxides, is a possible reason to explain the suppression of tumor growth observed in CuZnSOD-overexpressing cells.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Lu, X. Gong, Y. Lu, J. Guo, C. Wang, and Y. Pan
Molecular Cloning and Functional Characterization of a Cell-permeable Superoxide Dismutase Targeted to Lung Adenocarcinoma Cells: INHIBITION CELL PROLIFERATION THROUGH THE Akt/p27kip1 PATHWAY
J. Biol. Chem., May 12, 2006; 281(19): 13620 - 13627.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Alexandre, C. Nicco, C. Chereau, A. Laurent, B. Weill, F. Goldwasser, and F. Batteux
Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.
J Natl Cancer Inst, February 15, 2006; 98(4): 236 - 244.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. L. T. Teoh, P. V. Turner, and D. H. Evans
Tumorigenic Poxviruses Up-Regulate Intracellular Superoxide To Inhibit Apoptosis and Promote Cell Proliferation
J. Virol., May 1, 2005; 79(9): 5799 - 5811.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Laurent, C. Nicco, C. Chereau, C. Goulvestre, J. Alexandre, A. Alves, E. Levy, F. Goldwasser, Y. Panis, O. Soubrane, et al.
Controlling Tumor Growth by Modulating Endogenous Production of Reactive Oxygen Species
Cancer Res., February 1, 2005; 65(3): 948 - 956.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. P. Singh, N. Moniaux, S. C. Chauhan, J. L. Meza, and S. K. Batra
Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis
Cancer Res., January 15, 2004; 64(2): 622 - 630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. L. Kinnula and J. D. Crapo
Superoxide Dismutases in the Lung and Human Lung Diseases
Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1600 - 1619.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z.-y. Huang, Y. Wu, S. P. Burke, and D. H. Gutmann
The 43,000 Growth-associated Protein Functions as a Negative Growth Regulator in Glioma
Cancer Res., June 1, 2003; 63(11): 2933 - 2939.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Shukeir, A. Arakelian, S. Kadhim, S. Garde, and S. A. Rabbani
Prostate Secretory Protein PSP-94 Decreases Tumor Growth and Hypercalcemia of Malignancy in a Syngenic in Vivo Model of Prostate Cancer
Cancer Res., May 1, 2003; 63(9): 2072 - 2078.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Golab, D. Nowis, M. Skrzycki, H. Czeczot, A. Baranczyk-Kuzma, G. M. Wilczynski, M. Makowski, P. Mroz, K. Kozar, R. Kaminski, et al.
Antitumor Effects of Photodynamic Therapy Are Potentiated by 2-Methoxyestradiol. A SUPEROXIDE DISMUTASE INHIBITOR
J. Biol. Chem., January 3, 2003; 278(1): 407 - 414.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.